The current problems with increasing bacterial resistance to antibacterial therapies, resulting
in a growing frequency of incurable bacterial infections, necessitates the acceleration of …

Acinetobacter baumannii (A. baumannii) is a common nosocomial pathogen associated with
serious clinical challenges owing to its rapidly increasing resistance to antibiotics. Due to …

Acinetobacter baumannii is an opportunistic pathogen that significantly causes hospital-
acquired infections. Due to its multidrug resistance, treating infections caused by this …

Phage therapy is a viable alternative to antibiotics for treating microbial infections,
particularly managing drug-resistant strains of bacteria. One of the major challenges in …

Infections with the opportunistic Gram-negative bacterium Acinetobacter baumannii pose a
serious threat today, which is aggravated by the growing problem of multi-drug resistance …

Acinetobacter baumannii is an important nosocomial and opportunistic pathogen. It causes
infections worldwide, especially in intensive care units. It is clinically significant owing to its …

A lytic Acinetobacter baumannii phage, isolate vB_AbaM_AB3P2, was isolated from a
sewage treatment plant in China. A. baumannii phage vB_AbaM_AB3P2 has a dsDNA …

Temperate phages are potential therapeutic agents, but only a few temperate phages
infecting multidrug-resistant Acinetobacter baumannii have been identified. In this study, we …

Acinetobacter baumannii, notorious for causing nosocomial infections especially in patients
admitted to intensive care unit (ICU) and burn units, is best at displaying resistance to all …

Acinetobacter baumannii is a nosocomial pathogen, which is a problem worldwide due to
the emergence of a difficult-to-treat multidrug-resistant A. baumannii (MDRAB). Endolysins …